Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.
about
Metformin exhibits the anti-proliferation and anti-invasion effects in hepatocellular carcinoma cells after insufficient radiofrequency ablationEffect of a hypoxic microenvironment after radiofrequency ablation on residual hepatocellular cell migration and invasion.Gene isoforms as expression-based biomarkers predictive of drug response in vitro.MEIS-1 level in unresectable hepatocellular carcinoma can predict the post-treatment outcomes of radiofrequency ablation.A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma.
P2860
Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sorafenib suppresses the epith ...... cient radiofrequency ablation.
@ast
Sorafenib suppresses the epith ...... cient radiofrequency ablation.
@en
type
label
Sorafenib suppresses the epith ...... cient radiofrequency ablation.
@ast
Sorafenib suppresses the epith ...... cient radiofrequency ablation.
@en
prefLabel
Sorafenib suppresses the epith ...... cient radiofrequency ablation.
@ast
Sorafenib suppresses the epith ...... cient radiofrequency ablation.
@en
P2093
P2860
P1433
P1476
Sorafenib suppresses the epith ...... cient radiofrequency ablation.
@en
P2093
Fandong Kong
Jinge Kong
Lemin Zheng
Shuying Dong
Wenbing Sun
P2860
P2888
P356
10.1186/S12885-015-1949-7
P407
P577
2015-11-30T00:00:00Z
P5875
P6179
1048025843